P.A. Voûte

871 total citations
40 papers, 636 citations indexed

About

P.A. Voûte is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, P.A. Voûte has authored 40 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 17 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in P.A. Voûte's work include Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Biochemical and Molecular Research (6 papers). P.A. Voûte is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Biochemical and Molecular Research (6 papers). P.A. Voûte collaborates with scholars based in Netherlands, Chile and Canada. P.A. Voûte's co-authors include Jan de Kraker, André B. P. Kuilenburg, Albert H. Gennip, S.K. Wadman, C.A. Hoefnagel, Arnauld Verschuur, René Leen, Cornelis A. Hoefnagel, R.A. Valdés Olmos and Lou A. Smets and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, European Journal of Biochemistry and International Journal of Cancer.

In The Last Decade

P.A. Voûte

39 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.A. Voûte Netherlands 17 275 234 139 117 106 40 636
Vandana Batra United States 14 139 0.5× 189 0.8× 85 0.6× 70 0.6× 46 0.4× 31 453
Megha S. Uppin India 13 200 0.7× 85 0.4× 58 0.4× 70 0.6× 52 0.5× 57 549
Gang Shen China 15 364 1.3× 226 1.0× 230 1.7× 123 1.1× 284 2.7× 72 1.1k
Claudia Otto Germany 12 223 0.8× 132 0.6× 146 1.1× 60 0.5× 173 1.6× 34 852
Rosaire Vaillancourt Canada 11 292 1.1× 182 0.8× 33 0.2× 63 0.5× 250 2.4× 16 834
Chaim B. Colen United States 12 198 0.7× 77 0.3× 193 1.4× 49 0.4× 193 1.8× 17 593
Raymon Vijzelaar Netherlands 13 389 1.4× 35 0.1× 67 0.5× 88 0.8× 81 0.8× 29 652
John Mangiardi United States 14 67 0.2× 129 0.6× 23 0.2× 75 0.6× 139 1.3× 20 481
Yibin Zhang China 13 218 0.8× 90 0.4× 41 0.3× 79 0.7× 37 0.3× 54 502
Weiwei Fan China 15 216 0.8× 70 0.3× 54 0.4× 78 0.7× 110 1.0× 28 615

Countries citing papers authored by P.A. Voûte

Since Specialization
Citations

This map shows the geographic impact of P.A. Voûte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Voûte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Voûte more than expected).

Fields of papers citing papers by P.A. Voûte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Voûte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Voûte. The network helps show where P.A. Voûte may publish in the future.

Co-authorship network of co-authors of P.A. Voûte

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Voûte. A scholar is included among the top collaborators of P.A. Voûte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Voûte. P.A. Voûte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verschuur, Arnauld, et al.. (2002). Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1‐β‐D‐arabinofuranosyl cytosine in a human T‐lymphoblastic cell line. International Journal of Cancer. 98(4). 616–623. 23 indexed citations
2.
Verschuur, Arnauld, Albert H. Gennip, René Leen, P.A. Voûte, & André B. P. Kuilenburg. (2002). Cyclopentenyl Cytosine Induces Apoptosis and Secondary Necrosis in a T-Lymphoblastic Leukemic Cell-Line. Advances in experimental medicine and biology. 486. 319–325. 11 indexed citations
3.
Verschuur, Arnauld, et al.. (2001). Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line. Leukemia Research. 25(10). 891–900. 22 indexed citations
4.
Rutgers, Marja, et al.. (2000). Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: Tissue distribution, metabolism and therapeutic efficacy. International Journal of Cancer. 87(3). 412–422. 21 indexed citations
5.
Verschuur, Arnauld, A. H. van Gennip, René Leen, et al.. (2000). Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia. European Journal of Cancer. 36(5). 627–635. 29 indexed citations
6.
Verschuur, Arnauld, Albert H. Gennip, René Leen, et al.. (2000). In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia. British Journal of Haematology. 110(1). 161–169. 34 indexed citations
7.
Verschuur, Arnauld, Albert H. Gennip, Eliane J. Müller, P.A. Voûte, & André B. P. Kuilenburg. (1998). Increased Activity of Cytidine triphosphate Synthetase in Pediatric Acute Lymphoblastic Leukemia. Advances in experimental medicine and biology. 431. 667–671. 24 indexed citations
8.
9.
Verschuur, Arnauld, Albert H. Gennip, Eliane J. Müller, P.A. Voûte, & André B. P. Kuilenburg. (1997). Increased activity of cytidine triphosphate synthetase in pediatric acute lymphoblastic leukemia. Clinical Biochemistry. 30(3). 292–292. 1 indexed citations
10.
Hoefnagel, C.A., Jan de Kraker, R.A. Valdés Olmos, & P.A. Voûte. (1995). [131I]MIBG as a first line treatment in advanced neuroblastoma.. PubMed. 39(4 Suppl 1). 61–4. 16 indexed citations
11.
Slingerland, Robbert J., et al.. (1995). Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells. European Journal of Cancer. 31(4). 627–631. 6 indexed citations
12.
Slingerland, Robbert J., et al.. (1995). Compartmentation of Ribonucleotides in PC-12 Cells: Free and Protein Bound Ribonucleotides. Advances in experimental medicine and biology. 370. 283–286. 2 indexed citations
13.
Slingerland, Robbert J., et al.. (1995). Quantitative Analysis of the Pyrimidine Metabolism in Pheochromocytoma PC‐12 Cells. European Journal of Biochemistry. 233(2). 538–543. 13 indexed citations
14.
Voûte, P.A., et al.. (1995). Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV. European Journal of Cancer. 31(4). 596–600. 29 indexed citations
15.
Cornelissen, Jan J., et al.. (1995). Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line molt-4. Biochemical Pharmacology. 49(4). 471–477. 20 indexed citations
16.
Slingerland, Robbert J., et al.. (1995). Imbalance between the Pyrimidine Ribonucleotide Pools in Rat Rhabdomyosarcoma R1 Cells. Advances in experimental medicine and biology. 370. 279–282. 3 indexed citations
17.
Hoefnagel, C.A., P.A. Voûte, Jan de Kraker, et al.. (1988). Side effects of I-131-MIBG therapy of neural crest tumors. Australian and New Zealand Journal of Medicine. 18(3). 504. 1 indexed citations
18.
Loonen, Jacqueline J., J. van der Noordaa, Jan de Kraker, et al.. (1987). Alpha-Hemolytic Streptococcal Septicemia with Severe Complications During Neutropenia in Childhood Cancer. Pediatric Hematology and Oncology. 4(4). 323–328. 15 indexed citations
19.
Voûte, P.A., et al.. (1982). Simultaneous administration of nalidixic acid and high dose melphalan in children causing death due to severe side effects on the intestinal tract. European Journal of Cancer and Clinical Oncology. 18(10). 1047. 1 indexed citations
20.
Voûte, P.A., et al.. (1970). Congenital Neuroblastoma. Clinical Pediatrics. 9(4). 206–207. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vandana Batra Breakdown of academic impact, for papers by Megha S. Uppin Breakdown of academic impact, for papers by Gang Shen Breakdown of academic impact, for papers by Claudia Otto Breakdown of academic impact, for papers by Rosaire Vaillancourt Breakdown of academic impact, for papers by Chaim B. Colen Breakdown of academic impact, for papers by Raymon Vijzelaar Breakdown of academic impact, for papers by John Mangiardi Breakdown of academic impact, for papers by Yibin Zhang Breakdown of academic impact, for papers by Weiwei Fan
Rankless by CCL
2026